- Inlog S.A., Is Part of the Consortium Chosen by Assistance Publique - Hopitaux de Paris, Led by Agfa Healthcare, in One of the Largest European Healthcare Information System Projects DENVER, Dec. 2 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC:GLOB) (BULLETIN BOARD: GLOB) , an international e-Health, medical information technology company, today announced that its European subsidiary, Inlog S.A., has licensed its EdgeTrack Transfusion Software, marketed as "Hemo Serveur" in France, to 21 Assistance Publique - Hopitaux de Paris ("AP-HP") hospitals, representing 23,000 patient beds. For Global Med, this project represents over $2 million, at current exchange rates, in software and services. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) The computerization of blood transfusion in these 21 hospitals is part of the AP-HP's "Clinical Information System" project, which will install an electronic medical records System ("EMR") and ancillary systems in each of their establishments. This multi-million Euro award is led by Agfa Healthcare (Euronext: AGFB - FWB: AGE), which directs the consortium that also includes Cap Gemini, HP, Oracle and Global Med-Inlog. Benoit Leclercq, Chief Executive Officer of the AP-HP, commented about the Clinical Information System, "I am pleased with this collaboration, which results in a significant improvement in the handling of patients." EdgeTrack will ensure the complete tracking of blood products with real time communication with the computerized Agfa EMR System, ORBIS(TM). The application will interface with the French Blood Establishment ("EFS") which is also equipped with the Global Med-Inlog complete blood management solution, EdgeBlood. All 2.2 million units of blood collected in France are processed by the EdgeBlood product, marketed as "CTS Serveur" in France. Since EdgeTrack was introduced into the market in 1995 as "Hemo Serveur", it has become a leading hospital transfusion and traceability information management system in France with more than 100 licensed hospitals. EdgeTrack is connected with most laboratory management systems and hospital information systems, and is integrated with major blood transfusion information systems. Thomas F. Marcinek, President and Chief Operating Officer for Global Med Technologies, commented, "We are honored to be part of one of the largest healthcare information technology projects in Europe, and to have been chosen to collaborate on this ambitious project by such an elite group of healthcare technology companies as Agfa and Cap Gemini. We look forward to supporting AP-HP facilities with quality products and services as they continue to provide excellent, advanced healthcare to patients and the Paris community." About AP-HP (Assistance Publique - Hopitaux de Paris) The Assistance Publique - Hopitaux de Paris is a public health establishment serving the city of Paris. It undertakes the missions of health, education, medical research, prevention, healthcare education and emergency medical care. It includes the University Hospital Centre of the Ile-de-France. The AP-HP is made up of 37 hospitals or hospital groups and hospice care, which were joined in June 2003 into 4 university hospital groups: North, East, South and West. These groups allow the delivery of patient care, which is adapted to the specialties of each health domain in accordance with other hospital partners. The AP-HP is engaged in a modernization process of the whole establishment, which proves their dedication to provide safe and innovative patient care. For more information on AP-HP, visit their website at http://www.ap-hp.fr/. About Global Med Technologies(R), Inc. Global Med Technologies, Inc. is an international medical software company which develops regulated and non-regulated software products and services for the healthcare industry. As a leading provider of blood and laboratory software applications and services, Global Med's products are deployed in 20 countries and serve over 1,600 transfusion centers, blood banks and laboratories. Global Med's domestic companies are Wyndgate Technologies(R), which provides Vein-to-Vein(R) tracking through its Donor Doc(TM), SafeTrace(R), SafeTrace Tx(R) and ElDorado Donor(TM) software products; eDonor(R), which provides a web-based donor relationship management system that integrates recruitment, scheduling, retention and fulfillment for national as well as local community blood centers and hospitals; and PeopleMed(TM), Inc., which implements cost-effective customized software validation, consulting and compliance solutions to hospitals and donor centers. Global Med's European subsidiary, Inlog, SA, is a leading developer of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally. Inlog's products include EdgeBlood*, EdgeTrack*, EdgeCell, EdgeLab and SapaNet. For more information about Global Med's products and services, please call 800-996-3428 or visit http://www.globalmedtech.com/, http://www.peoplemed.com/, http://www.inlog.com/, http://www.edonor.com/, and http://www.wyndgate.com/. *FDA 510(k) clearance required prior to sales in the U.S. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I. Ruxin, M.D., of Global Med Technologies, Inc., +1-303-238-2000, , or Investors, Paul Holm, President of portfolio pr, +1-212-888-4570, , for Global Med Technologies, Inc. Web site: http://www.globalmedtech.com/ http://www.ap-hp.fr/

Copyright